dismiss

Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
Advertisement

 

advertisement

 

Cardiology Homepage

Apple study suggests wearable technology may be useful in detecting atrial fibrillation May assist in stroke and hospitalization prevention

FDA gives green light for smallest, slimmest 3T CRM devices Extended battery lives, greater diagnostic and therapeutic capabilities

Echocardiogram should play role in patient selection for transcatheter mitral valve repair, says study New study highlighted at ACC

Level Ex releases interventional cardiac video game, Cardio Ex Over 35 levels that test cognitive, spatial reasoning and decision-making skills

Siemens to unveil its SOMATOM go.Top Cardiovascular Edition CT at ACC 19 Ideal for the cardiovascular outpatient setting

FDA approves Sonavex's EchoSure system Monitors blood flow following surgical procedures

Siemens unveils Artis icono biplane angio system at ECR Enables diagnostics and treatment to take place in same lab, improved 2D and 3D capabilities

Noninvasive approach for imaging carotid artery shows promise Enables risk assessment for cardiovascular disease

Medtronic to acquire EPIX Therapeutics Will use EPIX's cardiac ablation technology with Medtronic's cryoballoon technology

John D. Zehren Endologix appoints chief commercial officer

A new test is capable of assessing
the flow of blood to determine if the
source of their pain is cardiac-related

Personalized cardiac test could eliminate unnecessary catheterizations

by John R. Fischer , Staff Reporter
Predicting which patients require cardiac catheterization is now easier for clinicians at the Yale School of Medicine.

The Ivy League med school is the first in Connecticut and one of a handful in the Northeast to try out a new, personalized cardiac test for examining blood flow to the heart, to accurately predict appropriate candidates for catheterization among patients with coronary artery disease at Yale New Haven Hospital.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510



“This new analysis is helping us develop the most appropriate treatment plan for a patient with coronary artery disease (CAD) without the need for unnecessary and stressful procedures,” said Dr. Hamid Mojibian, M.D., associate professor of radiology and cardiology at Yale School of Medicine, in a statement.

Current exams for assessing blood vessels and the heart are prone to false positives, especially in women.

Relying on algorithms to simulate blood flow and assess the impact of narrowed vessels on flow to the heart, the test collects data from a noninvasive coronary CT angiogram of the patient and compiles an analysis.

Based on this, it then creates a personalized, digital 3D model of the blood vessels, the use of which was found to identify which patients were in need of invasive treatment versus those that were not, in clinical trials.

One example is the case of a 73-year-old with multiple medical conditions that made the cause of chest pain he was feeling unclear. Following the completion of a coronary CT angiogram, the test found no significant arterial blockage of blood flow to the heart, ruling out cardiac as the source of the pain.

Its use, according to Mojibian, will help patients who do not require catheterization avoid unnecessary invasive angiography, a practice that patients with chest pain and shortness of breath often choose to undergo. A recent study from the New England Journal of Medicine asserts that such procedures are not necessary in many cases, finding no CAD in 39.2 percent of patients who received catheterization.

“This new analysis is helping us develop the most appropriate treatment plan for a patient with coronary artery disease (CAD) without the need for unnecessary and stressful procedures,” he said. “If 40 percent of diagnostic catheterizations in this situation are normal, we can use this new tool to make sure the right patients are getting cardiac catheterization as quickly as possible. We can reduce the number of false positives, thereby avoiding unnecessary catheterization, reducing complications, providing value and creating faster diagnosis.”

Back to HCB News
  Pages: 1

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED